NAMPT and glioblastoma: We evaluated NAMPT mRNA expression in commercial GBM cell lines and patient-derived GBM cultures using transcriptomic data from The Human Protein Atlas (THPA) (Figure 4A), selecting models with varying NAMPT levels for functional validation.